Precigen, Inc. Gross Margin

Gross Margin of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Gross Margin growth rates and interactive chart. Gross profit margin shows the percentage of revenue that exceeds a company's costs of goods sold. It illustrates how well a company is generating revenue from the costs involved in producing their products and services. The higher the margin, the more effective the company's management is in generating revenue for each dollar of cost. Gross profit margin is calculated by subtracting the cost of goods sold from total revenue for the period and dividing that number by revenue. If a company has $200 million in revenue and $80 million in cost of goods sold, the gross margin is 60%.

Highlights and Quick Summary

  • Gross Margin for the quarter ending December 31, 2022 was 42.82% (a -52.72% decrease compared to previous quarter)
  • Year-over-year quarterly Gross Margin decreased by -8.11%
  • Annual Gross Margin for 2022 was 76.44% (a 27.98% increase from previous year)
  • Annual Gross Margin for 2021 was 59.73% (a -28.21% decrease from previous year)
  • Annual Gross Margin for 2020 was 83.2% (a 157.43% increase from previous year)
  • Twelve month Gross Margin ending December 31, 2022 was 76.44% (a 10.0% increase compared to previous quarter)
  • Twelve month trailing Gross Margin increased by 39.77% year-over-year
Trailing Gross Margin for the last four month:
31 Dec '22 30 Sep '22 30 Jun '22 31 Mar '22
76.44% 69.49% 50.52% 54.69%
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Gross Margin of Precigen, Inc.

Most recent Gross Marginof PGEN including historical data for past 10 years.

Interactive Chart of Gross Margin of Precigen, Inc.

Precigen, Inc. Gross Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 42.82% 90.57% 37.79% 46.6% 76.44%
2021 42.31% 56.44% 64.61% 47.06% 59.73%
2020 29.9% 44.08% 50.99% 54.34% 83.2%
2019 9.36% 21.0% 49.08% 34.41% 32.32%
2018 60.04% 52.77% 59.06% 61.4% 58.54%
2017 78.52% 67.37% 69.05% 70.58% 71.89%
2016 68.78% 69.46% 67.46% 64.93% 67.72%
2015 63.95% 68.77% 59.31% 58.53% 63.18%
2014 59.37% 69.15% 99.55% 99.58% 73.22%
2013 100.0% 100.0% 100.0% 100.0% 99.91%
2012 100.0% 100.0% – – 100.0%

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com